REPORT ID 6971

EMEA (Europe, Middle East and Africa) Microbiome Therapeutics Market Report 2019

Publish Date
2019
Pages
129
Format
Electronic (PDF)

In this report, the EMEA Microbiome Therapeutics market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (), revenue (Million USD), market share and growth rate of Microbiome Therapeutics for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Microbiome Therapeutics market competition by top manufacturers/players, with Microbiome Therapeutics sales volume (), price (), revenue (Million USD) and market share for each manufacturer/player; the top players including
    C3 Jian
    Enterome Bioscience
    Immuron
    MicroBiome Therapeutics
    OpenBiome
    Osel
    Ritter Pharmaceuticals
    Second Genome
    Seres Therapeutics
    Synthetic Biologics
    4D Pharma
    AbbVie
    ActoGeniX
    Admera Health
    Advanced Technology Ventures
    Advancing Bio
    AgBiome
    AOBiome
    APC Microbiome Institute
    Assembly Biosciences
    Avid Biotics
    Azitra

On the basis of product, this report displays the sales volume (), revenue (Million USD), product price (), market share and growth rate of each type, primarily split into
    Probiotic Type
    Fructo-Oligosaccharides
    Galacto-Oligosaccharides
    Inulin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (), market share and growth rate of Microbiome Therapeutics for each application, including
    Antibiotic-Associated Diarrhoea (AAD)
    Infectious Childhood Diarrhoea
    Cholesterol
    Inflammatory Bowel Disease (IBD)
    Blood Pressure
    Lactose Intolerance
    Weight Loss
    Vitamin Production
    Bacterial Vaginosis (BV)
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Microbiome Therapeutics Market  Report 2019
1 Microbiome Therapeutics Overview
    1.1 Product Overview and Scope of Microbiome Therapeutics
    1.2 Classification of Microbiome Therapeutics
        1.2.1 EMEA Microbiome Therapeutics Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Microbiome Therapeutics Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Probiotic Type
        1.2.4 Fructo-Oligosaccharides
        1.2.5 Galacto-Oligosaccharides
        1.2.6 Inulin
    1.3 EMEA Microbiome Therapeutics Market by Application/End Users
        1.3.1 EMEA Microbiome Therapeutics Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Antibiotic-Associated Diarrhoea (AAD)
        1.3.3 Infectious Childhood Diarrhoea
        1.3.4 Cholesterol
        1.3.5 Inflammatory Bowel Disease (IBD)
        1.3.6 Blood Pressure
        1.3.7 Lactose Intolerance
        1.3.8 Weight Loss
        1.3.9 Vitamin Production
        1.3.10 Bacterial Vaginosis (BV)
        1.3.11 Others
    1.4 EMEA Microbiome Therapeutics Market by Region
        1.4.1 EMEA Microbiome Therapeutics Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Microbiome Therapeutics ( 2014-2024)
        1.5.1 EMEA Microbiome Therapeutics Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Microbiome Therapeutics Revenue and Growth Rate ( 2014-2024)

2 EMEA Microbiome Therapeutics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Microbiome Therapeutics Market Competition by Players/Manufacturers
        2.1.1 EMEA Microbiome Therapeutics Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Microbiome Therapeutics Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Microbiome Therapeutics Sale Price by Players ( 2014-2019)
    2.2 EMEA Microbiome Therapeutics (Volume and Value) by Type/Product Category
        2.2.1 EMEA Microbiome Therapeutics Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Microbiome Therapeutics Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Microbiome Therapeutics Sale Price by Type ( 2014-2019)
    2.3 EMEA Microbiome Therapeutics (Volume) by Application
    2.4 EMEA Microbiome Therapeutics (Volume and Value) by Region
        2.4.1 EMEA Microbiome Therapeutics Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Microbiome Therapeutics Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Microbiome Therapeutics Sales Price by Region ( 2014-2019)

3 Europe Microbiome Therapeutics (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Microbiome Therapeutics Sales and Value ( 2014-2019)
        3.1.1 Europe Microbiome Therapeutics Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Microbiome Therapeutics Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Microbiome Therapeutics Sales and Market Share by Type
    3.3 Europe Microbiome Therapeutics Sales and Market Share by Application
    3.4 Europe Microbiome Therapeutics Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Microbiome Therapeutics Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Microbiome Therapeutics Revenue by Countries ( 2014-2019)
        3.4.3 Germany Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        3.4.4 France Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)

4 Middle East Microbiome Therapeutics (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Microbiome Therapeutics Sales and Value ( 2014-2019)
        4.1.1 Middle East Microbiome Therapeutics Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Microbiome Therapeutics Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Microbiome Therapeutics Sales and Market Share by Type
    4.3 Middle East Microbiome Therapeutics Sales and Market Share by Application
    4.4 Middle East Microbiome Therapeutics Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Microbiome Therapeutics Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Microbiome Therapeutics Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)

5 Africa Microbiome Therapeutics (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Microbiome Therapeutics Sales and Value ( 2014-2019)
        5.1.1 Africa Microbiome Therapeutics Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Microbiome Therapeutics Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Microbiome Therapeutics Sales and Market Share by Type
    5.3 Africa Microbiome Therapeutics Sales and Market Share by Application
    5.4 Africa Microbiome Therapeutics Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Microbiome Therapeutics Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Microbiome Therapeutics Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Microbiome Therapeutics Sales and Growth Rate ( 2014-2019)

6 EMEA Microbiome Therapeutics Manufacturers/Players Profiles and Sales Data
    6.1 C3 Jian
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Microbiome Therapeutics Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 C3 Jian Microbiome Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Enterome Bioscience
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Microbiome Therapeutics Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Enterome Bioscience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Immuron
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Microbiome Therapeutics Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Immuron Microbiome Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 MicroBiome Therapeutics
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Microbiome Therapeutics Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 MicroBiome Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 OpenBiome
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Microbiome Therapeutics Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 OpenBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Osel
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Microbiome Therapeutics Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Osel Microbiome Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Ritter Pharmaceuticals
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Microbiome Therapeutics Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Second Genome
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Microbiome Therapeutics Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Seres Therapeutics
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Microbiome Therapeutics Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Synthetic Biologics
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Microbiome Therapeutics Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 4D Pharma
    6.12 AbbVie
    6.13 ActoGeniX
    6.14 Admera Health
    6.15 Advanced Technology Ventures
    6.16 Advancing Bio
    6.17 AgBiome
    6.18 AOBiome
    6.19 APC Microbiome Institute
    6.20 Assembly Biosciences
    6.21 Avid Biotics
    6.22 Azitra

7 Microbiome Therapeutics Manufacturing Cost Analysis
    7.1 Microbiome Therapeutics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Microbiome Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Microbiome Therapeutics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Microbiome Therapeutics Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Microbiome Therapeutics Market Forecast ( 2019-2025)
    11.1 EMEA Microbiome Therapeutics Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Microbiome Therapeutics Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Microbiome Therapeutics Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Microbiome Therapeutics Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Microbiome Therapeutics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Microbiome Therapeutics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Microbiome Therapeutics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Microbiome Therapeutics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Microbiome Therapeutics Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Microbiome Therapeutics Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer